Evidence map›Paper›PMID 27667444›Full record

ArticleScientific reports2016

Enhancement of trichothecene mycotoxins of Fusarium oxysporum by ferulic acid aggravates oxidative damage in Rehmannia glutinosa Libosch.

Zhen Fang Li, Chen Ling He, Ying Wang, Ming Jie Li, Ya Jing Dai, Tong Wang, Wenxiong Lin

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Mechanism of Action ofPlants (Basel, Switzerland) · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Functional analysis ofFrontiers in plant science · 2022
    Article
  11. Enrichment ofMicrobiology spectrum · 2021
    Article
  12. Autotoxin RgMicrobiology spectrum · 2021
    Article
  13. Article
  14. Plants (Basel, Switzerland) · 2020
    Article
  15. Article
  16. Frontiers in microbiology · 2020
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Zhen Fang LiCollege of Crop Sciences, Fujian Agriculture and Forestry University, Jinshan, Fuzhou 350002, P.R. China.
Chen Ling HeCollege of Crop Sciences, Fujian Agriculture and Forestry University, Jinshan, Fuzhou 350002, P.R. China.
Ying WangCollege of Life Sciences, Fujian Agriculture and Forestry University, Jinshan, Fuzhou 350002, P.R. China.
Ming Jie LiCollege of Crop Sciences, Fujian Agriculture and Forestry University, Jinshan, Fuzhou 350002, P.R. China.
Ya Jing DaiCollege of Crop Sciences, Fujian Agriculture and Forestry University, Jinshan, Fuzhou 350002, P.R. China.
Tong WangCollege of Crop Sciences, Fujian Agriculture and Forestry University, Jinshan, Fuzhou 350002, P.R. China.
Wenxiong LinCollege of Life Sciences, Fujian Agriculture and Forestry University, Jinshan, Fuzhou 350002, P.R. China.
Fujian Agriculture and Forestry University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rehmannia glutinosa is an important medicinal herb that cannot be replanted in the same field due to the effects of autotoxic substances. The effects of these substances on R. glutinosa in continuous cropping systems are unknown. In the present study, bioassays revealed that R. glutinosa exhibited severe growth restriction and higher disease indices in the FO+FA (F.oxysporum pretreated with ferulic acid) treatment. The increases in the contents of MDA and H

Identifiers

PMID27667444
PMCPMC5036203
OpenAlexW2525442433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.